This inventor holds 2 USPTO granted patents. Top assignee: Biosearch, LLC. Active years: 1991-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1992
Title: H Ruth Pyle: Innovator in Sustained Release Delivery Systems
Introduction
H Ruth Pyle is a notable inventor based in Fort Lauderdale, FL (US). She has made significant contributions to the field of pharmaceutical delivery systems, particularly in the development of multiphasic sustained release systems. With a total of 2 patents, her work focuses on improving the efficacy and safety of injectable treatments.
Latest Patents
H Ruth Pyle's latest patents include innovative systems for sustained release dosage forms. One patent describes a multiphasic sustained release injectable delivery system designed for treating humans and other mammals. This system allows for prolonged, controlled delivery of microencapsulated macromolecular bioactive agents. The design ensures that a small amount of the bioactive agent is released initially, minimizing adverse reactions while allowing for subsequent higher doses that could provoke a serious reaction in the patient. Another patent focuses on a similar multiphasic sustained release system for allergen extracts, which also aims to minimize initial allergenicity while providing effective treatment.
Career Highlights
H Ruth Pyle has established herself as a key figure in her field through her innovative work at Biosearch, LLC. Her research and development efforts have led to advancements in how medications and allergen extracts are delivered, enhancing patient safety and treatment outcomes.
Collaborations
H Ruth Pyle collaborates with Loui J Silvestri, contributing to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
H Ruth Pyle's contributions to sustained release delivery systems represent a significant advancement in medical treatment methodologies. Her innovative patents and collaborative efforts continue to shape the future of pharmaceutical delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile